• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《207 项描述皮肤病生活质量指数验证方面的研究的系统评价》

A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index.

机构信息

Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, UK.

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.

出版信息

Acta Derm Venereol. 2024 Nov 7;104:adv41120. doi: 10.2340/actadv.v104.41120.

DOI:10.2340/actadv.v104.41120
PMID:39508500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11559262/
Abstract

This study systematically analysed peer-reviewed publications describing validation aspects of the Dermatology Life Quality Index (DLQI) and used Naicker's Critically Appraising for Antiracism Tool to assess risk of racial bias. Seven online databases were searched from 1994 until 2022 for articles containing DLQI validation data. Methodology followed PRISMA guidelines, the protocol was registered in PROSPERO, and articles reviewed independently by two assessors. Of 1,717 screened publications, 207 articles including 58,828 patients from >  49 different countries and 41 diseases met the inclusion criteria. The DLQI demonstrated strong test-retest reliability; 43 studies confirmed good internal consistency. Twelve studies were performed using anchors to assess change responsiveness with effect sizes from small to large, giving confidence that the DLQI responds appropriately to change. Forty-two studies tested known-groups validity, providing confidence in construct and use of the DLQI over many parameters, including disease severity, anxiety, depression, stigma, scarring, well-being, sexual function, disease location and duration. DLQI correlation was demonstrated with 119 Patient Reported Outcomes/Quality of Life measures in 207 studies. Only 15% of studies explicitly recruited minority ethnic participants; 3.9% stratified results by race/ethnicity. This review summarizes knowledge concerning DLQI validation, confirms many strengths of the DLQI and identifies areas for further validation.

摘要

本研究系统分析了描述皮肤病生活质量指数(DLQI)验证方面的同行评审出版物,并使用 Naicker 的反种族主义批判性评估工具来评估种族偏见的风险。从 1994 年到 2022 年,在七个在线数据库中搜索了包含 DLQI 验证数据的文章。方法遵循 PRISMA 指南,该方案已在 PROSPERO 中注册,由两名评估员独立审查文章。在筛选出的 1717 篇出版物中,有 207 篇文章包括来自 49 个以上不同国家和 41 种疾病的 58828 名患者,符合纳入标准。DLQI 显示出较强的重测信度;43 项研究证实了良好的内部一致性。有 12 项研究使用锚定物来评估反应变化的响应性,其效果大小从小到大,这使人们有信心认为 DLQI 能够对变化做出适当反应。42 项研究检验了已知组有效性,在包括疾病严重程度、焦虑、抑郁、耻辱感、疤痕、幸福感、性功能、疾病位置和持续时间在内的许多参数方面,对 DLQI 的结构和使用提供了信心。在 207 项研究中,DLQI 与 119 项患者报告的结果/生活质量测量结果相关。只有 15%的研究明确招募少数民族参与者;3.9%的研究按种族/民族进行分层。本综述总结了关于 DLQI 验证的知识,确认了 DLQI 的许多优势,并确定了进一步验证的领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebda/11559262/5a3940a39a77/ActaDV-104-41120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebda/11559262/5a3940a39a77/ActaDV-104-41120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebda/11559262/5a3940a39a77/ActaDV-104-41120-g001.jpg

相似文献

1
A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index.《207 项描述皮肤病生活质量指数验证方面的研究的系统评价》
Acta Derm Venereol. 2024 Nov 7;104:adv41120. doi: 10.2340/actadv.v104.41120.
2
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review.皮肤病生活质量指数(DLQI)用作101种生活质量工具验证的基准:一项系统评价。
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):631-679. doi: 10.1111/jdv.20321. Epub 2024 Sep 13.
3
A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries.一项使用皮肤病生活质量指数的 454 项随机对照试验的系统评价:69 种疾病和 43 个国家的经验。
Br J Dermatol. 2024 Feb 16;190(3):315-339. doi: 10.1093/bjd/ljad079.
4
The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review.将皮肤病生活质量指数作为随机临床试验的主要结局指标:一项系统评价。
Br J Dermatol. 2024 Sep 18;191(4):497-507. doi: 10.1093/bjd/ljae228.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Cross validation of the Turkish version of dermatology life quality index.土耳其版皮肤病生活质量指数的交叉验证
Int J Dermatol. 2006 Nov;45(11):1300-7. doi: 10.1111/j.1365-4632.2006.02881.x.
7
Correlating the Dermatology Life Quality Index with psychiatric measures: A systematic review.皮肤病生活质量指数与精神科测量指标的相关性:一项系统评价。
Clin Dermatol. 2018 Nov-Dec;36(6):691-697. doi: 10.1016/j.clindermatol.2018.08.014. Epub 2018 Aug 16.
8
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.1994 - 2007年皮肤病生活质量指数:验证数据与临床结果的全面综述
Br J Dermatol. 2008 Nov;159(5):997-1035. doi: 10.1111/j.1365-2133.2008.08832.x. Epub 2008 Sep 15.
9
Validation study of Sinhala version of the dermatology life quality index (DLQI).僧伽罗语版皮肤病生活质量指数(DLQI)的验证研究。
Ceylon Med J. 2011 Mar;56(1):18-22. doi: 10.4038/cmj.v56i1.2890.
10
Questionnaire Modifications and Alternative Scoring Methods of the Dermatology Life Quality Index: A Systematic Review.皮肤病生活质量指数的问卷修订和替代评分方法:系统评价。
Value Health. 2021 Aug;24(8):1158-1171. doi: 10.1016/j.jval.2021.02.006. Epub 2021 Apr 21.

引用本文的文献

1
Advantages of Mohs Surgery in the Treatment of NMSC in the Head and Neck District.莫氏手术在头颈部非黑色素瘤皮肤癌治疗中的优势。
J Clin Med. 2025 Jul 4;14(13):4732. doi: 10.3390/jcm14134732.

本文引用的文献

1
Evaluating the effect of weekly patient-reported symptom monitoring on trial outcomes: results of the Eczema Monitoring Online randomized controlled trial.评估每周患者报告症状监测对试验结局的影响:在线湿疹监测随机对照试验的结果。
Br J Dermatol. 2023 Jul 17;189(2):180-187. doi: 10.1093/bjd/ljad163.
2
A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries.一项使用皮肤病生活质量指数的 454 项随机对照试验的系统评价:69 种疾病和 43 个国家的经验。
Br J Dermatol. 2024 Feb 16;190(3):315-339. doi: 10.1093/bjd/ljad079.
3
Comorbidity of psychiatric and dermatologic disorders with skin picking disorder and validation of the Skin Picking Scale Revised for Brazilian Portuguese.
精神和皮肤疾病与皮肤搔抓障碍的共病情况,以及巴西葡萄牙语修订版皮肤搔抓量表的验证。
Braz J Psychiatry. 2022 Oct 7;44(6):621-627. doi: 10.47626/1516-4446-2021-2400.
4
A Cross-Sectional Study on the Relationship Between Rosacea Severity and Quality of Life or Psychological State.一项关于酒渣鼻严重程度与生活质量或心理状态之间关系的横断面研究。
Clin Cosmet Investig Dermatol. 2022 Dec 20;15:2807-2816. doi: 10.2147/CCID.S390921. eCollection 2022.
5
Racial disparities in dermatology.皮肤科的种族差异。
Arch Dermatol Res. 2023 Jul;315(5):1215-1223. doi: 10.1007/s00403-022-02507-z. Epub 2022 Dec 12.
6
Restless legs syndrome in patients with psoriasis: association with inflammation and sleep quality.银屑病患者的不宁腿综合征:与炎症和睡眠质量的关联
Int J Dermatol. 2023 Apr;62(4):501-507. doi: 10.1111/ijd.16532. Epub 2022 Dec 5.
7
Impact of Vitiligo on Life Quality of Patients: Assessment of Currently Available Tools.白癜风对患者生活质量的影响:现有工具评估。
Int J Environ Res Public Health. 2022 Nov 13;19(22):14943. doi: 10.3390/ijerph192214943.
8
Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns - a cross-sectional study.银屑病患者的心理(共病):瘙痒和生殖器受累对抑郁和焦虑症状及躯体变形障碍的影响 - 一项横断面研究。
BMJ Open. 2022 Sep 23;12(9):e055477. doi: 10.1136/bmjopen-2021-055477.
9
Genital Psoriasis: A Prospective, Observational, Single-Centre Study on Prevalence, Clinical Features, Risk Factors, and Its Impact on Quality of Life and Sexual Health.生殖器银屑病:一项关于患病率、临床特征、危险因素及其对生活质量和性健康影响的前瞻性、观察性、单中心研究。
Indian J Dermatol. 2022 Mar-Apr;67(2):205. doi: 10.4103/ijd.ijd_754_21.
10
The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.韩国一项真实世界研究:慢性自发性荨麻疹症状患者的负担。
Korean J Intern Med. 2022 Sep;37(5):1050-1060. doi: 10.3904/kjim.2022.078. Epub 2022 Sep 1.